During the development of nasal polyps, EMT leads to a shift from epithelial characteristics to mesenchymal traits, characterized by a decrease in epithelial markers (E-cadherin and EpCAM) and an increase in mesenchymal markers (vimentin, FBN, and N-cadherin) 5-8. This evidence concerns the gene CDH2 and Nasal polyposis.